2023 has been the year of headlines, hype and anxiety about generative artificial intelligence and its capabilities, and biopharma is among the many business sectors trying to figure out how the technology could boost productivity.
Interest in AI was evident at the Jefferies healthcare conference in London last week, where attendees crammed into the room to hear a talk by the Boston
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?